RELMADA THERAPEUTICS, INC. (RLMD) Net Cash Provided by (Used in) Financing Activities USD 2013 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Relmada Therapeutics, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2013 to 2024.
  • Relmada Therapeutics, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $222 K.
  • Relmada Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was -$98.5 K, a 100% decline from 2022.
  • Relmada Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $45 M, a 76% decline from 2021.
  • Relmada Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $188 M, a 560% increase from 2020.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $222 K Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q1 2022 $29.9 M +$28 M +1453% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q1 2021 $1.93 M -$1.08 M -35.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q1 2020 $3 M +$1.37 M +83.3% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-12
Q3 2019 $1.17 M +$848 K +265% Jul 1, 2019 Sep 30, 2019 10-Q 2019-11-13
Q1 2019 $1.64 M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
Q3 2018 $320 K -$3.64 M -91.9% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-13
Q3 2017 $3.96 M +$4.06 M Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-13
Q3 2016 -$109 K -$21.9 K -25.1% Jul 1, 2016 Sep 30, 2016 10-Q 2016-11-10
Q3 2015 -$87.3 K -$4.25 M -102% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-10
Q3 2014 $4.16 M +$1.36 M +48.5% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-06
Q1 2014 -$45.5 K Jan 1, 2014 Mar 31, 2014 8-K 2014-05-27
Q3 2013 $2.8 M Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.